MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-12-2026
PerkinElmer ROCE Ratio 2011-2026 | PKI
Annual ROCE Ratio PerkinElmer
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.92 | 4.52 | 3.82 | 17.62 | 5.24 | - | 5.66 | 6.47 | 8.17 | 6.96 | - | 5.96 | 6.5 | 2.82 | 6.65 | 2.61 | 9.41 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 17.62 | 2.61 | 6.49 |
Quarterly ROCE Ratio PerkinElmer
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.31 | 4.5 | 4.48 | 3.84 | 2.89 | 3.79 | 3.54 | 3.4 | 2.84 | 4.41 | 6.75 | 9.4 | 8.46 | 22.12 | 23.36 | 27.96 | 36.0 | 30.01 | 33.12 | 26.9 | 15.21 | 20.13 | 15.25 | 12.59 | 12.86 | 12.43 | 12.73 | 12.88 | 12.53 | 11.79 | 11.81 | 11.36 | 11.81 | 11.73 | 12.16 | 12.37 | 13.34 | 12.96 | 12.22 | 11.31 | 8.36 | 9.86 | 9.45 | 10.06 | 10.32 | 13.48 | 13.51 | 12.12 | 11.42 | 5.17 | 4.49 | 5.04 | 5.08 | 9.21 | 8.84 | 8.29 | 8.58 | 8.47 | 9.21 | 2.17 | 2.43 | 2.59 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 36.0 | 2.17 | 11.29 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
Celcuity
CELC
|
-171.24 | $ 92.59 | 5.9 % | $ 4.33 B | USA |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 4.5 | -10.89 % | $ 5.99 M | USA |
 |
Fulgent Genetics
FLGT
|
-8.19 | $ 18.5 | 1.04 % | $ 569 M | USA |
 |
Castle Biosciences
CSTL
|
-9.09 | $ 21.08 | 4.77 % | $ 611 M | USA |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
63.01 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
ICON Public Limited Company
ICLR
|
4.82 | $ 151.82 | -0.28 % | $ 11.9 B |  Irlanda |
 |
Illumina
ILMN
|
29.64 | $ 160.03 | 1.26 % | $ 24.8 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
440.3 | $ 130.12 | 4.19 % | $ 16.3 B | USA |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 22.75 | 3.64 % | $ 1.21 B | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-69.04 | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 1.74 | 3.57 % | $ 7.7 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
NeoGenomics
NEO
|
-9.11 | $ 11.44 | 4.47 % | $ 1.47 B | USA |
 |
Genetron Holdings Limited
GTH
|
-119.91 | - | 0.12 % | $ 80.1 M | China |
 |
National Research Corporation
NRC
|
161.47 | $ 19.75 | 2.17 % | $ 442 M | USA |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 99.98 | -0.03 % | $ 6.75 B | USA |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 189.85 | 1.83 % | $ 9.41 B | USA |
 |
Pacific Biosciences of California
PACB
|
-10354.48 | $ 1.37 | -0.72 % | $ 411 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 466.79 | 1.94 % | $ 13.5 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 162.79 | 2.1 % | $ 24 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 4.54 | 3.42 % | $ 420 M | USA |
 |
Natera
NTRA
|
-18.1 | $ 222.82 | 4.38 % | $ 30.5 B | USA |
 |
Personalis
PSNL
|
-33.71 | $ 9.75 | -2.89 % | $ 870 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
7.33 | $ 26.5 | 2.63 % | $ 25.1 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-111.94 | $ 7.43 | 4.21 % | $ 310 M | USA |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
2.09 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-125.14 | $ 2.05 | -0.92 % | $ 4.71 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 271.24 | 3.52 % | $ 22.6 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-28.81 | $ 70.06 | 0.03 % | $ 4.19 B | USA |
 |
Thermo Fisher Scientific
TMO
|
14.5 | $ 494.07 | 5.23 % | $ 186 B | USA |
 |
Trinity Biotech plc
TRIB
|
-29.73 | $ 0.66 | -2.32 % | $ 237 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 9.29 | 2.43 % | $ 2.01 B | USA |
 |
Waters Corporation
WAT
|
7.05 | $ 371.15 | 2.15 % | $ 22.1 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 204.53 | 3.71 % | $ 22.7 B | USA |